Literature DB >> 8261775

MULCOX2: a general computer program for the Cox regression analysis of multivariate failure time data.

D Y Lin1.   

Abstract

Multivariate failure time data is commonly encountered in biomedicine, because each study subject may experience multiple events or because there exists clustering of subjects such that failure times within the same cluster are correlated. MULCOX2 implements a general statistical methodology for analyzing such data. This approach formulates the marginal distributions of multivariate failure times by Cox proportional hazards models without specifying the nature of dependence among related failure times. The baseline hazard functions for the marginal models may be identical or different. A variety of statistical inference can be made regarding the effects of (possibly time-dependent) covariates on the failure rates. Although designed primarily for the marginal approach, MULCOX2 is general enough to implement several alternative methods. The program runs on any computer with a FORTRAN compiler. The running time is minimal. Two illustrative examples are provided.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8261775     DOI: 10.1016/0169-2607(93)90013-b

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  7 in total

1.  Unemployment and early cause-specific mortality: a study based on the Swedish twin registry.

Authors:  Margaretha Voss; Lotta Nylén; Birgitta Floderus; Finn Diderichsen; Paul D Terry
Journal:  Am J Public Health       Date:  2004-12       Impact factor: 9.308

2.  Dependence estimation for marginal models of multivariate survival data.

Authors:  M R Segal; J M Neuhaus; I R James
Journal:  Lifetime Data Anal       Date:  1997       Impact factor: 1.588

3.  Early photocoagulation in patients with either type I or type II diabetes.

Authors:  F Ferris
Journal:  Trans Am Ophthalmol Soc       Date:  1996

4.  Living arrangements, changes in living arrangements, and survival among community dwelling older adults.

Authors:  M A Davis; D J Moritz; J M Neuhaus; J D Barclay; L Gee
Journal:  Am J Public Health       Date:  1997-03       Impact factor: 9.308

5.  Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.

Authors:  Gregory P Bisson; Ritesh Ramchandani; Sachiko Miyahara; Rosie Mngqibisa; Mitch Matoga; McNeil Ngongondo; Wadzanai Samaneka; Lucy Koech; Kogieleum Naidoo; Mohammed Rassool; Fredrick Kirui; Peter Banda; Vidya Mave; Dileep Kadam; Paul Leger; German Henestroza; Yukari C Manabe; Jing Bao; Johnstone Kumwenda; Amita Gupta; Mina C Hosseinipour
Journal:  AIDS       Date:  2017-10-23       Impact factor: 4.177

6.  Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).

Authors:  Kristy Kummerow Broman; Tasha Hughes; Lesly Dossett; James Sun; Dennis Kirichenko; Michael J Carr; Avinash Sharma; Edmund K Bartlett; Amanda A G Nijhuis; John F Thompson; Tina J Hieken; Lisa Kottschade; Jennifer Downs; David E Gyorki; Emma Stahlie; Alexander van Akkooi; David W Ollila; Jill Frank; Yun Song; Giorgos Karakousis; Marc Moncrieff; Jenny Nobes; John Vetto; Dale Han; Jeffrey M Farma; Jeremiah L Deneve; Martin D Fleming; Matthew C Perez; Michael C Lowe; Roger Olofsson Bagge; Jan Mattsson; Ann Y Lee; Russell S Berman; Harvey Chai; Hidde M Kroon; Juri Teras; Roland M Teras; Norma E Farrow; Georgia Beasley; Jane Yuet Ching Hui; Lukas Been; Schelto Kruijff; Youngchul Kim; Syeda Mahrukh Hussnain Naqvi; Amod A Sarnaik; Vernon K Sondak; Jonathan S Zager
Journal:  Cancer       Date:  2021-04-07       Impact factor: 6.921

7.  Allergic conditions and risk of hematological malignancies in adults: a cohort study.

Authors:  Karin C Söderberg; Lars Hagmar; Judith Schwartzbaum; Maria Feychting
Journal:  BMC Public Health       Date:  2004-11-04       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.